Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,432,944
-
Share change
-
-4,199,755
-
Total reported value
-
$4,035,092,849
-
Put/Call ratio
-
53%
-
Price per share
-
$113.88
-
Number of holders
-
197
-
Value change
-
-$233,619,311
-
Number of buys
-
123
-
Number of sells
-
87
Institutional Holders of SPARK THERAPEUTICS INC - COM (ONCE) as of Q1 2019
As of 31 Mar 2019,
SPARK THERAPEUTICS INC - COM (ONCE) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,432,944 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FEDERATED INVESTORS INC /PA/, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, Casdin Capital, LLC, Magnetar Financial LLC, Beryl Capital Management LLC, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
197
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.